awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36938779-CC3A3D05-9BF9-4B77-909E-F9902E68C40F
Q36938779-CC3A3D05-9BF9-4B77-909E-F9902E68C40F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36938779-CC3A3D05-9BF9-4B77-909E-F9902E68C40F
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.
P2860
Q36938779-CC3A3D05-9BF9-4B77-909E-F9902E68C40F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36938779-CC3A3D05-9BF9-4B77-909E-F9902E68C40F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ddfcbd9ab261775e697473e74bfc1ee45467ba4e
P2860
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.